170 related articles for article (PubMed ID: 33941126)
21. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
[TBL] [Abstract][Full Text] [Related]
22. Differences in Human Papillomavirus Vaccination Among Adolescent Girls in Metropolitan Versus Non-metropolitan Areas: Considering the Moderating Roles of Maternal Socioeconomic Status and Health Care Access.
Monnat SM; Rhubart DC; Wallington SF
Matern Child Health J; 2016 Feb; 20(2):315-25. PubMed ID: 26511129
[TBL] [Abstract][Full Text] [Related]
23. Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV.
Alder S; Gustafsson S; Perinetti C; Mints M; Sundström K; Andersson S
Oncol Rep; 2015 May; 33(5):2521-8. PubMed ID: 25738832
[TBL] [Abstract][Full Text] [Related]
24. The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
Skufca J; Ollgren J; Artama M; Ruokokoski E; Nohynek H; Palmu AA
Vaccine; 2018 Sep; 36(39):5926-5933. PubMed ID: 30115524
[TBL] [Abstract][Full Text] [Related]
25. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
[TBL] [Abstract][Full Text] [Related]
26. Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis.
Agimas MC; Adugna DG; Derseh NM; Kassaw A; Kassie YT; Abate HK; Mekonnen CK
BMC Public Health; 2024 Mar; 24(1):842. PubMed ID: 38500046
[TBL] [Abstract][Full Text] [Related]
27. Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
Feiring B; Laake I; Molden T; Håberg SE; Nøkleby H; Seterelv SS; Magnus P; Trogstad L
Vaccine; 2016 Apr; 34(17):2015-20. PubMed ID: 26947498
[TBL] [Abstract][Full Text] [Related]
28. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates.
Jeudin P; Liveright E; Del Carmen MG; Perkins RB
Clin Ther; 2014 Jan; 36(1):24-37. PubMed ID: 24417783
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus and cervical cancer risk perception and vaccine acceptability among adolescent girls and young women in Durban, South Africa.
Russell VL; Ogilvie G; Beksinska M; Nyrenda M; Mitchell-Foster S; Lavoie J; Harder H; Wood B; Smith P; Dietrich JJ; Smit J; Brockman MA; Gray G; Kaida On Behalf Of The Ayazazi Research Team A
S Afr Med J; 2020 Aug; 110(9):887-893. PubMed ID: 32880274
[TBL] [Abstract][Full Text] [Related]
30. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
Lim ASE; Lim RBT
Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
[TBL] [Abstract][Full Text] [Related]
31. Geographic variation in human papillomavirus vaccination uptake among 13-17 year old adolescent girls in the United States.
Rahman M; McGrath CJ; Berenson AB
Vaccine; 2014 May; 32(21):2394-8. PubMed ID: 24637175
[TBL] [Abstract][Full Text] [Related]
32. Addressing health inequalities in the delivery of the human papillomavirus vaccination programme: examining the role of the school nurse.
Boyce T; Holmes A
PLoS One; 2012; 7(9):e43416. PubMed ID: 23028452
[TBL] [Abstract][Full Text] [Related]
33. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis.
Fisher H; Trotter CL; Audrey S; MacDonald-Wallis K; Hickman M
Int J Epidemiol; 2013 Jun; 42(3):896-908. PubMed ID: 23620381
[TBL] [Abstract][Full Text] [Related]
34. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
Moss JL; Reiter PL; Brewer NT
Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
[TBL] [Abstract][Full Text] [Related]
35. Prospects and challenges in the introduction of human papillomavirus vaccines in the extended Middle East and North Africa region.
Jumaan AO; Ghanem S; Taher J; Braikat M; Al Awaidy S; Dbaibo GS
Vaccine; 2013 Dec; 31 Suppl 6():G58-64. PubMed ID: 24331821
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus vaccination in immigrants and descendants of immigrants in Denmark.
Hertzum-Larsen R; Thomsen LT; Frederiksen K; Kjær SK
Eur J Cancer Prev; 2020 Mar; 29(2):149-156. PubMed ID: 31425314
[TBL] [Abstract][Full Text] [Related]
37. The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South Africa.
Snyman LC; Dreyer G; Botha MH; van der Merwe FH; Becker PJ
S Afr Med J; 2015 Jan; 105(2):115-20. PubMed ID: 26242529
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus vaccine disease impact beyond expectations.
de Sanjose S; Brotons M; LaMontagne DS; Bruni L
Curr Opin Virol; 2019 Dec; 39():16-22. PubMed ID: 31382121
[TBL] [Abstract][Full Text] [Related]
39. Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme.
Muhamad NA; Buang SN; Jaafar S; Jais R; Tan PS; Mustapha N; Lodz NA; Aris T; Sulaiman LH; Murad S
BMC Public Health; 2018 Dec; 18(1):1402. PubMed ID: 30577816
[TBL] [Abstract][Full Text] [Related]
40. Vaccine Hesitancy Drives Low Human Papillomavirus Vaccination Coverage in Girls Attending Public Schools in South Africa.
Khosa LA; Meyer JC; Motshwane FMM; Dochez C; Burnett RJ
Front Public Health; 2022; 10():860809. PubMed ID: 35685759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]